Guggenheim Capital’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-25,987
| Closed | -$1.36M | – | 2164 |
|
|
2020
Q3 | $1.36M | Buy |
+25,987
| New | +$1.36M | 0.01% | 1066 |
|
|
2019
Q2 | – | Sell |
-11,125
| Closed | -$162K | – | 2207 |
|
|
2019
Q1 | $162K | Sell |
11,125
-265
| -2% | -$3.86K | ﹤0.01% | 2105 |
|
|
2018
Q4 | $126K | Sell |
11,390
-28,447
| -71% | -$315K | ﹤0.01% | 2113 |
|
|
2018
Q3 | $1.05M | Buy |
39,837
+5,483
| +16% | +$144K | 0.01% | 1592 |
|
|
2018
Q2 | $702K | Sell |
34,354
-86,245
| -72% | -$1.76M | ﹤0.01% | 1771 |
|
|
2018
Q1 | $2.19M | Buy |
120,599
+6,210
| +5% | +$113K | 0.01% | 1564 |
|
|
2017
Q4 | $1.6M | Buy |
114,389
+68,730
| +151% | +$958K | ﹤0.01% | 1824 |
|
|
2017
Q3 | $847K | Buy |
45,659
+2,920
| +7% | +$54.2K | ﹤0.01% | 2174 |
|
|
2017
Q2 | $721K | Sell |
42,739
-2,272
| -5% | -$38.3K | ﹤0.01% | 2251 |
|
|
2017
Q1 | $602K | Sell |
45,011
-4,889
| -10% | -$65.4K | ﹤0.01% | 2317 |
|
|
2016
Q4 | $751K | Buy |
+49,900
| New | +$751K | ﹤0.01% | 2273 |
|
|
2016
Q2 | – | Sell |
-197,517
| Closed | -$1.83M | – | 2962 |
|
|
2016
Q1 | $1.83M | Sell |
197,517
-22,515
| -10% | -$208K | 0.01% | 1640 |
|
|
2015
Q4 | $3.27M | Buy |
220,032
+123,459
| +128% | +$1.83M | 0.01% | 1273 |
|
|
2015
Q3 | $1.59M | Buy |
+96,573
| New | +$1.59M | ﹤0.01% | 1762 |
|
|
2014
Q4 | – | Sell |
-191,633
| Closed | -$2.17M | – | 3106 |
|
|
2014
Q3 | $2.17M | Buy |
191,633
+22,610
| +13% | +$256K | 0.01% | 1686 |
|
|
2014
Q2 | $2.04M | Sell |
169,023
-30,651
| -15% | -$370K | 0.01% | 1774 |
|
|
2014
Q1 | $2.33M | Buy |
199,674
+41,036
| +26% | +$478K | 0.01% | 1653 |
|
|
2013
Q4 | $2.81M | Buy |
+158,638
| New | +$2.81M | 0.01% | 1464 |
|